SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Scienture Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.92−0.44 (-13.10%)
Close on Oct 19, 2026
- Market cap
- $115.68M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Scienture has not reported a dividend
No dividend per share appears in Scienture's annual filings since fiscal 2012.